Holdings of EQ/T.Rowe Price Health Sciences Portfolio
EQ Advisors Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 159M $ including 158.2M $ in equities, 99.5 %
- Positions
- 168 in 14 countries
- Top ten
- 40.0 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | WaVe Life Sciences Ltd | 33,493 | 242.8K $ | 0.15 % |
| 102 | Kestra Medical Technologies Ltd | 12,124 | 241.6K $ | 0.15 % |
| 103 | Charles River Laboratories International Inc | 1,400 | 241.5K $ | 0.15 % |
| 104 | Tarsus Pharmaceuticals Inc | 3,388 | 237.7K $ | 0.15 % |
| 105 | Disc Medicine Inc | 3,569 | 228.2K $ | 0.14 % |
| 106 | Allogene Therapeutics Inc | 92,282 | 225.2K $ | 0.14 % |
| 107 | Cogent Biosciences Inc | 5,712 | 219.9K $ | 0.14 % |
| 108 | Tango Therapeutics Inc | 10,000 | 209.2K $ | 0.13 % |
| 109 | Replimune Group Inc | 27,145 | 207.7K $ | 0.13 % |
| 110 | Molina Healthcare Inc | 1,513 | 201.7K $ | 0.13 % |
| 111 | Sartorius AG | 822 | 200.6K $ | 0.13 % |
| 112 | Kyverna Therapeutics Inc | 22,961 | 198.2K $ | 0.12 % |
| 113 | Viatris Inc | 14,600 | 197.2K $ | 0.12 % |
| 114 | Pharvaris NV | 6,972 | 197K $ | 0.12 % |
| 115 | Ocular Therapeutix Inc | 22,500 | 190.6K $ | 0.12 % |
| 116 | Climb Bio Inc | 27,800 | 190.4K $ | 0.12 % |
| 117 | Ideaya Biosciences Inc | 5,631 | 187.6K $ | 0.12 % |
| 118 | Tyra Biosciences Inc | 4,800 | 183.8K $ | 0.12 % |
| 119 | Biohaven Ltd | 21,694 | 183.5K $ | 0.12 % |
| 120 | Corvus Pharmaceuticals Inc | 12,357 | 180.8K $ | 0.11 % |
| 121 | Olema Pharmaceuticals Inc | 11,900 | 177.4K $ | 0.11 % |
| 122 | Shattuck Labs Inc | 26,700 | 171.7K $ | 0.11 % |
| 123 | Medpace Holdings Inc | 350 | 168.1K $ | 0.11 % |
| 124 | Denali Therapeutics Inc | 8,698 | 167K $ | 0.11 % |
| 125 | Iovance Biotherapeutics Inc | 45,491 | 159.7K $ | 0.10 % |
| 126 | Generate Biomedicines Inc | 12,700 | 158.8K $ | 0.10 % |
| 127 | Cullinan Therapeutics Inc | 10,800 | 153.5K $ | 0.10 % |
| 128 | PROCEPT BIOROBOTICS CORP | 6,032 | 150.9K $ | 0.09 % |
| 129 | Liquidia Corp | 3,938 | 148.6K $ | 0.09 % |
| 130 | Lantheus Holdings Inc | 1,900 | 144.1K $ | 0.09 % |
| 131 | Atrium Therapeutics Inc | 10,400 | 139K $ | 0.09 % |
| 132 | Viridian Therapeutics Inc | 6,379 | 124.8K $ | 0.08 % |
| 133 | Entrada Therapeutics Inc | 9,365 | 118.2K $ | 0.07 % |
| 134 | Xencor Inc | 9,370 | 113K $ | 0.07 % |
| 135 | SpyGlass Pharma Inc | 4,214 | 109.2K $ | 0.07 % |
| 136 | SENSORION SA | 227,583 | 108.5K $ | 0.07 % |
| 137 | ZAI LAB LTD | 5,474 | 103K $ | 0.06 % |
| 138 | Agios Pharmaceuticals Inc | 2,991 | 101.2K $ | 0.06 % |
| 139 | IMMATICS NV | 10,100 | 99.4K $ | 0.06 % |
| 140 | Inspire Medical Systems Inc | 1,900 | 98K $ | 0.06 % |
| 141 | Bicycle Therapeutics PLC | 20,819 | 96.6K $ | 0.06 % |
| 142 | Alto Neuroscience Inc | 4,100 | 92.2K $ | 0.06 % |
| 143 | Evommune Inc | 4,008 | 92.1K $ | 0.06 % |
| 144 | Aktis Oncology Inc | 4,864 | 87K $ | 0.05 % |
| 145 | CRESCENT BIOPHARMA INC | 4,414 | 81.1K $ | 0.05 % |
| 146 | Immuneering Corp | 12,686 | 66.9K $ | 0.04 % |
| 147 | Rocket Pharmaceuticals Inc | 16,956 | 60.7K $ | 0.04 % |
| 148 | Annexon Inc | 10,634 | 58.9K $ | 0.04 % |
| 149 | BridgeBio Oncology Therapeutics Inc | 6,580 | 58.9K $ | 0.04 % |
| 150 | Tectonic Therapeutic Inc | 1,900 | 58.7K $ | 0.04 % |
| 151 | Eikon Therapeutics Inc | 5,071 | 53.7K $ | 0.03 % |
| 152 | Aura Biosciences Inc | 7,297 | 48.8K $ | 0.03 % |
| 153 | Immix Biopharma Inc | 5,000 | 45.6K $ | 0.03 % |
| 154 | Hims & Hers Health Inc | 1,700 | 35.3K $ | 0.02 % |
| 155 | SALUDA MEDICAL INC | 57,441 | 32.9K $ | 0.02 % |
| 156 | Immunovant Inc | 1,300 | 32.3K $ | 0.02 % |
| 157 | Enliven Therapeutics Inc | 800 | 31.4K $ | 0.02 % |
| 158 | Monopar Therapeutics Inc | 571 | 31.3K $ | 0.02 % |
| 159 | RadNet Inc | 423 | 23.6K $ | 0.01 % |
| 160 | LENZ Therapeutics Inc | 2,554 | 23.4K $ | 0.01 % |
| 161 | Adlai Nortye Ltd. | 3,368 | 23.3K $ | 0.01 % |
| 162 | Beta Bionics Inc | 1,821 | 18.2K $ | 0.01 % |
| 163 | Nuvation Bio Inc | 3,852 | 16.5K $ | 0.01 % |
| 164 | Janux Therapeutics Inc | 1,122 | 15.6K $ | 0.01 % |
| 165 | MediWound Ltd | 946 | 15.2K $ | 0.01 % |
| 166 | Tenax Therapeutics Inc | 842 | 13.5K $ | 0.01 % |
| 167 | Ginkgo Bioworks Holdings Inc | 1,346 | 8.3K $ | 0.01 % |
| 168 | Cabaletta Bio Inc | 1,057 | 2.8K $ | 0.00 % |
Sector breakdown
- Health care 66.1 %
- Unattributed 33.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.7 %
- HKD 1.3 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.2 %
The quoted currency of each line, as declared.
Country breakdown
- United States 86.9 %
- United Kingdom 3.3 %
- Netherlands 3.2 %
- Denmark 1.7 %
- Bermuda 1.3 %
- Hong Kong SAR China 1.3 %
- Cayman Islands 0.6 %
- Japan 0.6 %
- France 0.5 %
- Switzerland 0.2 %
- Singapore 0.2 %
- Germany 0.1 %
- Other countries 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 146 | 137.4M $ | 86.85 % |
| 2 | United Kingdom | 2 | 5.2M $ | 3.29 % |
| 3 | Netherlands | 3 | 5.1M $ | 3.24 % |
| 4 | Denmark | 2 | 2.6M $ | 1.66 % |
| 5 | Bermuda | 2 | 2.1M $ | 1.33 % |
| 6 | Hong Kong SAR China | 1 | 2M $ | 1.25 % |
| 7 | Cayman Islands | 4 | 957.2K $ | 0.61 % |
| 8 | Japan | 1 | 951.6K $ | 0.60 % |
| 9 | France | 2 | 830.4K $ | 0.53 % |
| 10 | Switzerland | 1 | 389.7K $ | 0.25 % |
| 11 | Singapore | 1 | 242.8K $ | 0.15 % |
| 12 | Germany | 1 | 200.6K $ | 0.13 % |
Cite this page
Titelia. "Holdings of EQ/T.Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000062644